RAPORSIN

This brand name is authorized in Ireland, UK.

Active ingredients

The drug RAPORSIN contains one active pharmaceutical ingredient (API):

1
UNII 86P6PQK0MU - DOXAZOSIN MESYLATE
 

Doxazosin is a potent and selective post-junctional alpha-1-adrenoceptor antagonist. This action results in a decrease in systemic blood pressure.
 
Read more about Doxazosin

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 RAPORSIN XL Prolonged-release tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C02CA04 Doxazosin C Cardiovascular system → C02 Antihypertensives → C02C Antiadrenergic agents, peripherally acting → C02CA Alpha-adrenoreceptor antagonists
Discover more medicines within C02CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
GB Medicines & Healthcare Products Regulatory Agency 181650
IE Health Products Regulatory Authority 29215, 53915, 53922

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈